Kinnosuke Matsumoto

5PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical and biological physics not elsewhere classifiedInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 03, 2026
Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non-Squamous Non-Small Cell Lung Cancer: A Multicenter Retrospective Study.

|Jan 30, 2026
Impact of Sequential Ramucirumab Plus Docetaxel After PD-1 Inhibitors on Anti-PD-1 Antibody-Bound T-Cell Dynamics and Clinical Outcomes.

Kinnosuke Matsumoto, Yujiro Naito, Takayuki Shiroyama

|Jan 14, 2022
Management of severe hypertension due to lenvatinib in patients with advanced thymic carcinoma: A case report.

Kinnosuke Matsumoto, Takayuki Shiroyama, Kotaro Miyake

|Feb 19, 2021
Mediastinal undifferentiated pleomorphic sarcoma with pleural effusion cytopathologically misdiagnosed as epithelial malignant pleural mesothelioma: An autopsy case report.

Kinnosuke Matsumoto, Yukihiro Nakamura, Yuji Inagaki

|Feb 20, 2020
Efficacy and tolerance of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung disease.

Kinnosuke Matsumoto, Yuichi Adachi, Takatoshi Enomoto

Pageof 1

Frequent Collaborators

1 joint publications

Takatoshi Enomoto

1 joint publications

Takayuki Shiroyama

1 joint publications

Akihiro Tamiya

1 joint publications

Toshiyuki Minami